Cedars-Sinai GI Virtual Power Hour: Advances in Immunotherapy for Gastrointestinal Cancers

Wednesday, November 24, 2021, 12:00 AM - Wednesday, November 30, 2022, 11:59 PM, Online


The Cedars-Sinai GI Virtual Power Hour: Advances in Immunotherapy for Gastrointestinal Cancers will provide concise updates on the most recent research and advances in immunotherapy for gastrointestinal cancers. Expert faculty has been assembled to share developments in precision medicine, research, virtual reality in oncology practice and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, rectal and colorectal. This activity will enhance your understanding of GI cancers and provide you with valuable information to inform your clinical decision-making and treatment approaches for your patients.

1. Consider advances in biomarkers and immunotherapy to better inform treatment decision-making for patients with gastroesophageal cancers
2. Use AJCC or other appropriate staging in clinical practice, including the use of appropriate prognostic indicators and evidence-based national guidelines for treatment planning
3. Evaluate the basic science of immune therapy for GI malignancies and the implications for transfer from bench to bedside
4. Increase knowledge of immunotherapy for neuroendocrine tumors and biomarker identification of novel immunotherapies
5. Identify and implement optimal strategies for managing immune-related side effects and toxicities in patients treated with immunotherapy agents
6. Anticipate the needs, problems, and issues of cancer survivors and develop an individualized wellness plan in partnership with cancer survivors, their families and the healthcare team

Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Cedars-Sinai Medical Center designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician Attendance
A certificate of participation will be provided to other health care professionals requesting credits. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.

Acknowledgment of Commercial Support
Cedars-Sinai gratefully acknowledges educational grants from AstraZeneca, Bristol Myers Squib and Ipsen. 

AMA PRA Category 1 Credit(s)™ (MD, DO) (1.00 hours), Non-Physician AMA Attendance (1.00 hours)

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.